Knockdown of fascin-1 expression suppresses cell migration and invasion of non-small cell lung cancer by regulating the MAPK pathway

被引:37
|
作者
Zhao, Da [1 ]
Zhang, Tao [1 ]
Hou, Xiao-Ming [1 ]
Ling, Xiao-Ling [1 ]
机构
[1] Lanzhou Univ, Hosp 1, Dept Oncol, 1 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China
关键词
NSCLC; Fascin-1; Proliferation; Invasion; Migration; MAPK signaling; INHIBITS MIGRATION;
D O I
10.1016/j.bbrc.2018.02.134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fascin-1 is a cytoskeletal protein and it can specifically bind to F-actin, it can be abnormally expressed in a variety of solid tumors. Fascin-1 was identified as a factor for poor prognosis in non-small cell lung cancer (NSCLC). However, the relevant molecular mechanisms are not yet fully understood. In this study, the fascin-1 knockdown cells were produced by lentivirus infection, and then cell proliferation, invasion and cell migration assay were used to investigate the role of fascin-1 in NSCLC cells. The MAPK pathway related proteins were determined by western blot. In the current study, lentivirus-mediated fascin-1 knockdown significantly decreased the proliferation of NSCLC cells. Furthermore, fascin-1 silencing partly inhibited cell invasion and migration. Inhibition of fascin-1 decreased the activity of the MAPK pathway. Therefore, targeting fascin-1 may inhibit the growth and metastasis of NSCLC cells, which is a potentially effective therapeutic strategy for treating NSCLC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 50 条
  • [1] Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer
    Hu, Jing
    Zhang, LiBin
    Chen, Qiang
    Lin, Jie
    Wang, ShaoBo
    Liu, Ri
    Zhang, WenJing
    Miao, Kun
    Shou, Tao
    [J]. CELL BIOLOGY INTERNATIONAL, 2018, 42 (11) : 1484 - 1491
  • [2] Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
    Ling, Xiao-Ling
    Zhang, Tao
    Hou, Xiao-Ming
    Zhao, Da
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 1589 - 1595
  • [3] Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis
    SUN Bing-sheng
    YOU Jian
    LI Yue
    ZHANG Zhen-fa
    WANG Chang-li
    [J]. 中华医学杂志(英文版), 2013, 126 (09) : 1683 - 1688
  • [4] Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis
    Sun Bing-sheng
    You Jian
    Li Yue
    Zhang Zhen-fa
    Wang Chang-li
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (09) : 1683 - 1688
  • [5] CCR1 knockdown suppresses human non-small cell lung cancer cell invasion
    Chang-Li Wang
    Bing-Sheng Sun
    Yong Tang
    Hong-Qing Zhuang
    Wei-Zhi Cao
    [J]. Journal of Cancer Research and Clinical Oncology, 2009, 135
  • [6] CCR1 knockdown suppresses human non-small cell lung cancer cell invasion
    Wang, Chang-Li
    Sun, Bing-Sheng
    Tang, Yong
    Zhuang, Hong-Qing
    Cao, Wei-Zhi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (05) : 695 - 701
  • [7] Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
    Li, Dan
    Li, Weimin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [8] Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition
    Xu, Xiang
    Zhu, Huangkai
    Yang, Minglei
    Zheng, Enkuo
    Zhou, Yinjie
    Ni, Junjun
    Li, Rui
    Yang, Zhenhua
    He, Ti
    Zhao, Guofang
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) : 1925 - 1932
  • [9] Fascin-1 promotes breast cancer cell invasion by regulating expression of LGR5
    Ito, Yuki
    Ishihara, Seiichiro
    Haga, Hisashi
    [J]. CANCER SCIENCE, 2018, 109 : 857 - 857
  • [10] TOB1-AS1 suppresses non-small cell lung cancer cell migration and invasion through a ceRNA network
    Shangguan, Wen-Ji
    Liu, Hai-Tao
    Que, Zu-Jun
    Qian, Fang-Fang
    Liu, Ling-Shuang
    Tian, Jian-Hui
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4249 - 4258